gadolinium dtpa has been researched along with Ectopic Hormone Syndromes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, H; Kobayashi, S; Yoshimoto, T | 1 |
Crozat, N; Gerber, S; Marro, B; Marsault, C; Sag, K; Sahel, M; Sourour, N; Zouaoui, A | 1 |
Cutler, GB; Doppman, JL; Dwyer, AJ; Frank, JA; Hickey, AM; Loriaux, DL; Oldfield, EH; Schiable, TF | 1 |
3 other study(ies) available for gadolinium dtpa and Ectopic Hormone Syndromes
Article | Year |
---|---|
A clinical and histopathological study of factors affecting MRI signal intensities of pituitary adenomas.
Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Cell Count; Contrast Media; Drug Combinations; Female; Follicle Stimulating Hormone; Gadolinium DTPA; Growth Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Paraneoplastic Endocrine Syndromes; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin | 1994 |
MRI of pituitary adenomas in acromegaly.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Child; Contrast Media; Female; Follicle Stimulating Hormone; Gadolinium DTPA; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Paraneoplastic Endocrine Syndromes; Pentetic Acid; Pituitary Gland; Pituitary Neoplasms; Prolactinoma | 1997 |
Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging.
Topics: ACTH Syndrome, Ectopic; Adenoma; Contrast Media; Cushing Syndrome; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Spectroscopy; Organometallic Compounds; Paraneoplastic Endocrine Syndromes; Pentetic Acid; Pituitary Neoplasms; Tomography, X-Ray Computed | 1987 |